EDGAR Filing Documents for 0001193125-18-340078

Form 8-K - Current report:

SEC Accession No. 0001193125-18-340078

Filing Date

2018-12-03

Accepted

2018-11-30 20:21:36

Documents

Period of Report

2018-11-28

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d667158d8k.htm	8-K	32225
2	EX-10.1	d667158dex101.htm	EX-10.1	32588
3	EX-10.2	d667158dex102.htm	EX-10.2	33978
4	EX-10.3	d667158dex103.htm	EX-10.3	182694
5	EX-10.4	d667158dex104.htm	EX-10.4	34835
6	EX-10.5	d667158dex105.htm	EX-10.5	36921
7	EX-10.6	d667158dex106.htm	EX-10.6	36041
8	GRAPHIC	g667158dsp1.jpg	GRAPHIC	3878
	Complete submission text file	0001193125-18-340078.txt		396224

Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878

Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450

Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)